#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Advanced systemic mastocytosis Intracranial germ cell tumour Ornithine transcarbamoylase deficiency Cold type haemolytic anaemia Congenital leptin deficiency Insulinoma Hereditary angioedema Nephrotic syndrome Turner's syndrome Transient ischaemic attack Pulmonary sarcoidosis Neovascular age-related macular degeneration Von Hippel-Lindau disease Chronic cutaneous lupus erythematosus Piriformis syndrome More trials…

    Learn about Rare Diseases

    Osteosarcoma – Trials in Disease Ornithine transcarbamoylase deficiency Mucopolysaccharidosis III – Diagnostics VEXAS syndrome – Diagnostics Glomerulonephritis rapidly progressive – Treatment Haemophilia A with anti factor VIII Retinoblastoma – Treatment Mucopolysaccharidosis I Amyotrophic lateral sclerosis – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tasimelteon ABBV-CLS-628 Alendronic Acid CARBACHOL Erythromycin Lactobionate Magnesium Milademetan Zongertinib Dimeticone S095035 Gtaexs617 Antiemetics And Antinauseants Magnesium Chloride Hexahydrate NORETHISTERONE ACETATE Vidofludimus Calcium Quinine Dihydrochloride GSKVX000000070250 Sodium Hyaluronate Luspatercept Neomycin Sulfate More therapies…

    Learn about Your Condition

    Immune system disorder Neurofibrosarcoma Wolfram syndrome Catatonia Castleman's disease Procedural hypotension Hernia repair Eclampsia Cryoglobulinaemia Hypophosphatasia Fibromyalgia Klinefelter's syndrome Hyponatraemia Epicondylitis Diarrhoea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Children’s Health Medical Center EOOD

Children’s Health Medical Center EOOD

Ulitsa Maestro Kinev 2 A, Sofia, 1618, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of ACP-204 Tartrate for Adults With Lewy Body Dementia Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy

  • A Study Testing ACP-204 Tartrate Compared to Placebo for Adults with Lewy Body Dementia Psychosis

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy

  • Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

    Recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • (1S)-1-[4-[3-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]PROPOXY]-3-METHOXYPHENYL]ETHANOL
    Bulgaria Czechia Germany Poland

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    • Salbutamol
    Austria Bulgaria Czechia Denmark Finland France +10

  • Phase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Bulgaria Denmark France Germany Greece Hungary +4

  • A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Belgium Bulgaria Croatia Denmark Hungary +8

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!